Fluconazole-resistant Cryptococcus neoformans isolated from an immunocompetent patient without prior exposure to fluconazole

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1592-1593

  Orni Wasserlauf, Ruth ^a,c   Izkhakov, Elena ^a   Siegman Igra, Yardena ^a   Bash, Edna ^a   Polacheck, Itzhack ^b   Giladi, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; FUNGUS ANTIGEN; PYRROLE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRYPTOCOCCUS NEOFORMANS; DIPLOPIA; FUNGAL MENINGITIS; HEADACHE; HUMAN; IMMUNOCOMPETENCE; INFECTION RESISTANCE; MALE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; OPTIC NERVE DISEASE; PRIORITY JOURNAL; VERTIGO; VOMITING;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FLUCONAZOLE; FLUCYTOSINE; HUMANS; IMMUNOCOMPETENCE; MALE; MENINGITIS;

EID: 0033395765     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313546     Document Type: Article

References (9)

1. 1. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988; 157:624-8.
2. 2. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326:83-9.
3. 3. Yamaguchi H, Ikemoto H, Watanabe K, Ito A, Hara K, Kohno S. Fluconazole monotherapy for cryptococcosis in non-AIDS patients. Eur J Clin Microbiol Infect Dis 1996; 15:787-92.
4. 4. Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L, The Cryptococcosis Study Group. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 1996; 22(Suppl 2):S154-60.
5. 5. Berg J, Cornelius JC, Hong Nguyen M. The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin Infect Dis 1998; 26: 186-7.
6. 6. Armengou A, Porcar C, Mascaro J, Gracia-Bragado F. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 1996; 23:1337-8.
7. 7. Paugam A, Dupouy-Camet J, Blanche P, Gangneux JP, Tourte-Schaefer C, Sicard D. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis 1994; 19:975-6.
8. 8. Peetermans W, Bobbaers H, Verhaegen J, Vandepitte J. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient. Acta Clin Belg 1993; 48:405-9.
9. 9. Petter R, Amalfitano G, Mondon P, et al. Fluconazole heteroresistance in Cryptococcus neoformans [abstract c-12]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington, DC: American Society for Microbiology, 1997.